title: Improvement in chronic renal impairment following the discontinuation of tenofovir in two HIV-infected patients.
authors.forename: David
authors.initials: D
authors.lastname: Gracey
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Post
authors.forename: Colin
authors.initials: C
authors.lastname: MacLeod
authors.forename: Paul
authors.initials: P
authors.lastname: McKenzie
mesh_terms: D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives*; D019380:Anti-HIV Agents / Q000009:adverse effects*; D023241:Antiretroviral Therapy, Highly Active; D015415:Biomarkers / Q000097:blood; D001706:Biopsy; D002908:Chronic Disease; D003404:Creatinine / Q000097:blood; D057915:Drug Substitution; D005919:Glomerular Filtration Rate; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007668:Kidney / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D007674:Kidney Diseases / Q000097:blood / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D063065:Organophosphonates / Q000009:adverse effects*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*; D000068698:Tenofovir
chemical_list: D019380:Anti-HIV Agents; D015415:Biomarkers; D063065:Organophosphonates; D018894:Reverse Transcriptase Inhibitors; D000068698:Tenofovir; D003404:Creatinine; D000225:Adenine